Article in mSphere, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.
0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
2 · The registry
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Andrea I Boyd *Department of Molecular Virology and Microbiology, Baylor College of Medicine, Houston, Texas, USA.ORCID 0000-0003-4079-4813
Leah A Kafer *Department of Molecular Virology and Microbiology, Baylor College of Medicine, Houston, Texas, USA.ORCID 0000-0002-7355-9636
Isabel F EscapaDepartment of Molecular Virology and Microbiology, Baylor College of Medicine, Houston, Texas, USA.ORCID 0000-0002-1454-7205
Amal KambalDepartment of Molecular Virology and Microbiology, Baylor College of Medicine, Houston, Texas, USA.
Hira TariqDepartment of Molecular Virology and Microbiology, Baylor College of Medicine, Houston, Texas, USA.
Susan G HilsenbeckDuncan Cancer Center, Baylor College of Medicine, Houston, Texas, USA.
Hoa Nguyen-PhucDepartment of Molecular Virology and Microbiology, Baylor College of Medicine, Houston, Texas, USA.
Anubama RajanDepartment of Molecular Virology and Microbiology, Baylor College of Medicine, Houston, Texas, USA.
Joshua M LensmireDepartment of Molecular Virology and Microbiology, Baylor College of Medicine, Houston, Texas, USA.
Kathryn A PatrasDepartment of Molecular Virology and Microbiology, Baylor College of Medicine, Houston, Texas, USA.ORCID 0000-0003-2631-8810
Pedro A PiedraDepartment of Molecular Virology and Microbiology, Baylor College of Medicine, Houston, Texas, USA.ORCID 0000-0002-0100-2919
Sarah E BluttDepartment of Molecular Virology and Microbiology, Baylor College of Medicine, Houston, Texas, USA.
Katherine P LemonDepartment of Molecular Virology and Microbiology, Baylor College of Medicine, Houston, Texas, USA.ORCID 0000-0003-1542-1679
Funding
Tumor BiologyP30CA125123 · NCI · BAYLOR COLLEGE OF MEDICINE · PI DAVID R ROWLEY · 2007 to 2026
$73.9M
Viral Diversity and Pathogenicity in Mucosal Respiratory and Gastrointestinal DiseaseU19AI144297 · NIAID · BAYLOR COLLEGE OF MEDICINE · PI ESTES, MARY KOLB, GIBBS, RICHARD A · 2019 to 2024
$30.1M
Tissue Analysis & Molecular Imaging CoreP30DK056338 · NIDDK · BAYLOR COLLEGE OF MEDICINE · PI Geoffrey A Preidis · 2001 to 2026
$28.3M
Translational Research Support CoreP30ES030285 · NIEHS · BAYLOR COLLEGE OF MEDICINE · PI Cheryl L. Walker · 2019 to 2026
$14.7M
Novel Platforms for Human Intestinal Enteroids: Matrix, Mechanics, and TopographyU19AI116497 · NIAID · BAYLOR COLLEGE OF MEDICINE · PI GRANDE-ALLEN, KATHRYN JANE · 2015 to 2025
$13.2M
Organoid Cultivation CoreU19AI157981 · NIAID · BAYLOR COLLEGE OF MEDICINE · PI BRITTON, ROBERT A, LEMON, KATHERINE PAIGE · 2021 to 2025
$12.4M
Developmental Reprogramming of Prostate Carcinogenesis by BPARC2ES018789 · NIEHS · UNIVERSITY OF TX MD ANDERSON CAN CTR · PI HO, SHUK-MEI, MANCINI, MICHAEL A. · 2009 to 2010
$1.9M
Effect of Mucins and Dolosigranlulum pigrum on Staphylococcus aureus nasal colonizationF31AI172324 · NIAID · BAYLOR COLLEGE OF MEDICINE · PI BOYD, ANDREA IVEY · 2023 to 2025
$146k
National Institute of Allergy and Infectious Diseases F31AI172324National Institute of Allergy and Infectious Diseases U19AI116497National Institute of Allergy and Infectious Diseases U19AI144297National Institute of Allergy and Infectious Diseases U19AI157981NCI NIH HHS P30 CA125123NIAID NIH HHS F31 AI172324NIAID NIH HHS U19 AI116497NIAID NIH HHS U19 AI144297NIAID NIH HHS U19 AI157981NIDDK NIH HHS P30 DK056338NIEHS NIH HHS P30 ES030285NIEHS NIH HHS RC2 ES018789
6 · The paper itself
Abstract
Nasal colonization by IMPORTANCE: Human nasal microbiota often includes highly pathogenic members, many of which are antimicrobial resistance threats, e.g., methicillin-resistant
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.
Nasal microbionts differentially colonize and elicit cytokines in human nasal epithelial organoids. · full record | OpenQuestion